Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of Wendan Tablets in mild to moderate generalized anxiety disorder
CTR20252945Phase 3Active
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Sep 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Wendan Tablets with Placebo (2 arms). Primary endpoint: Change from baseline in HAMA total score at Week 12. Started Sep 2025; status: active.
02
Drugs
wendan decoction
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on CTR20252945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252945.